Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1016805.RA-5XALeeeHsxAEtZBuvF1ONyb-8usgGvkLL0ijdODJz0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1016805.RA-5XALeeeHsxAEtZBuvF1ONyb-8usgGvkLL0ijdODJz0130_assertion type Assertion NP1016805.RA-5XALeeeHsxAEtZBuvF1ONyb-8usgGvkLL0ijdODJz0130_head.
- NP1016805.RA-5XALeeeHsxAEtZBuvF1ONyb-8usgGvkLL0ijdODJz0130_assertion description "[Differential expression of both SPRY4 and SPRY4-IT1 was also detected in vivo, in 30 distinct patient samples, classified as primary in situ, regional metastatic, distant metastatic, and nodal metastatic melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1016805.RA-5XALeeeHsxAEtZBuvF1ONyb-8usgGvkLL0ijdODJz0130_provenance.
- NP1016805.RA-5XALeeeHsxAEtZBuvF1ONyb-8usgGvkLL0ijdODJz0130_assertion evidence source_evidence_literature NP1016805.RA-5XALeeeHsxAEtZBuvF1ONyb-8usgGvkLL0ijdODJz0130_provenance.
- NP1016805.RA-5XALeeeHsxAEtZBuvF1ONyb-8usgGvkLL0ijdODJz0130_assertion SIO_000772 21558391 NP1016805.RA-5XALeeeHsxAEtZBuvF1ONyb-8usgGvkLL0ijdODJz0130_provenance.
- NP1016805.RA-5XALeeeHsxAEtZBuvF1ONyb-8usgGvkLL0ijdODJz0130_assertion wasDerivedFrom befree-20150227 NP1016805.RA-5XALeeeHsxAEtZBuvF1ONyb-8usgGvkLL0ijdODJz0130_provenance.
- NP1016805.RA-5XALeeeHsxAEtZBuvF1ONyb-8usgGvkLL0ijdODJz0130_assertion wasGeneratedBy ECO_0000203 NP1016805.RA-5XALeeeHsxAEtZBuvF1ONyb-8usgGvkLL0ijdODJz0130_provenance.